Wellnex Life Ltd
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth w… Read more
Wellnex Life Ltd (WNX) - Net Assets
Latest net assets as of June 2025: AU$11.25 Million AUD
Based on the latest financial reports, Wellnex Life Ltd (WNX) has net assets worth AU$11.25 Million AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$27.84 Million) and total liabilities (AU$16.59 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$11.25 Million |
| % of Total Assets | 40.41% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | 15.82% |
| Growth Volatility | 392.17 |
Wellnex Life Ltd - Net Assets Trend (2013–2024)
This chart illustrates how Wellnex Life Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wellnex Life Ltd (2013–2024)
The table below shows the annual net assets of Wellnex Life Ltd from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | AU$11.25 Million | +85.63% |
| 2023-12-31 | AU$6.06 Million | +920.20% |
| 2022-12-31 | AU$594.00K | -86.37% |
| 2021-12-31 | AU$4.36 Million | +1850.60% |
| 2020-12-31 | AU$-249.00K | -108.83% |
| 2019-12-31 | AU$2.82 Million | -94.52% |
| 2018-12-31 | AU$51.44 Million | -16.41% |
| 2017-12-31 | AU$61.54 Million | +781.65% |
| 2016-12-31 | AU$6.98 Million | -28.13% |
| 2015-12-31 | AU$9.71 Million | +1019.22% |
| 2014-12-31 | AU$-1.06 Million | -42.72% |
| 2013-12-31 | AU$-740.32K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wellnex Life Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 14023167900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$151.45 Million | 1346.32% |
| Other Comprehensive Income | AU$776.00K | 6.90% |
| Other Components | AU$1.00 | 0.00% |
| Total Equity | AU$11.25 Million | 100.00% |
Wellnex Life Ltd Competitors by Market Cap
The table below lists competitors of Wellnex Life Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ignite Ltd
AU:IGN
|
$1.77 Million |
|
Millennium Group International Holdings Limited Ordinary Shares
NASDAQ:MGIH
|
$1.77 Million |
|
WABTEC
BE:WB2
|
$1.78 Million |
|
XTAAF
OTCGREY:XTAAF
|
$1.78 Million |
|
Caspar
WAR:CSR
|
$1.77 Million |
|
Syntholene Energy Corp.
V:ESAF
|
$1.77 Million |
|
Mercanto Holdings Inc.
PINK:TGSHF
|
$1.77 Million |
|
Oberstdorfer Bergbahn AG
MU:KVO
|
$1.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wellnex Life Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,060,000 to 11,249,000, a change of 5,189,000 (85.6%).
- Net loss of 15,604,000 reduced equity.
- Share repurchases of 15,900,000 reduced equity.
- Other comprehensive income decreased equity by 1,309,001.
- Other factors increased equity by 38,002,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-15.60 Million | -138.71% |
| Share Repurchases | AU$15.90 Million | -141.35% |
| Other Comprehensive Income | AU$-1.31 Million | -11.64% |
| Other Changes | AU$38.00 Million | +337.83% |
| Total Change | AU$- | 85.63% |
Book Value vs Market Value Analysis
This analysis compares Wellnex Life Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.20x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | AU$-0.42 | AU$0.08 | x |
| 2014-12-31 | AU$-0.56 | AU$0.08 | x |
| 2015-12-31 | AU$6.67 | AU$0.08 | x |
| 2016-12-31 | AU$2.34 | AU$0.08 | x |
| 2017-12-31 | AU$15.76 | AU$0.08 | x |
| 2018-12-31 | AU$12.62 | AU$0.08 | x |
| 2019-12-31 | AU$5.25 | AU$0.08 | x |
| 2020-12-31 | AU$-0.04 | AU$0.08 | x |
| 2021-12-31 | AU$0.54 | AU$0.08 | x |
| 2022-12-31 | AU$0.03 | AU$0.08 | x |
| 2023-12-31 | AU$0.36 | AU$0.08 | x |
| 2024-12-31 | AU$0.38 | AU$0.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wellnex Life Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -138.71%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -66.05%
- • Asset Turnover: 0.85x
- • Equity Multiplier: 2.47x
- Recent ROE (-138.71%) is above the historical average (-263.99%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | -34.76% | 1.06x | 0.00x | AU$-84.11K |
| 2014 | 0.00% | -21002.06% | 0.00x | 0.00x | AU$-210.63K |
| 2015 | -5.51% | -5367.68% | 0.00x | 1.04x | AU$-1.51 Million |
| 2016 | -59.47% | -447.10% | 0.12x | 1.13x | AU$-4.85 Million |
| 2017 | -32.35% | -1376.34% | 0.02x | 1.05x | AU$-25.96 Million |
| 2018 | -19.19% | -1117.36% | 0.02x | 1.13x | AU$-15.08 Million |
| 2019 | -184.11% | -4953.53% | 0.05x | 0.77x | AU$-48.78 Million |
| 2020 | 0.00% | -2065.94% | 0.11x | 0.00x | AU$-24.66 Million |
| 2021 | -170.89% | -40.03% | 0.95x | 4.50x | AU$-7.88 Million |
| 2022 | -2330.98% | -49.64% | 1.85x | 25.32x | AU$-13.91 Million |
| 2023 | -226.72% | -81.14% | 0.55x | 5.10x | AU$-14.35 Million |
| 2024 | -138.71% | -66.05% | 0.85x | 2.47x | AU$-16.73 Million |
Industry Comparison
This section compares Wellnex Life Ltd's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $87,459,454
- Average return on equity (ROE) among peers: -114.51%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wellnex Life Ltd (WNX) | AU$11.25 Million | 0.00% | 1.47x | $1.77 Million |
| Australian Dairy Nutritionals Ltd (AHF) | $26.73 Million | -27.52% | 0.14x | $7.62 Million |
| Beston Global Food Company Ltd (BFC) | $113.64 Million | -1.66% | 0.03x | $3.27 Million |
| Biome Australia Ltd (BIO) | $6.53 Million | -69.59% | 0.26x | $32.26 Million |
| Bioxyne Ltd (BXN) | $1.18 Million | -369.02% | 1.02x | $21.29 Million |
| Cobram Estate Olives Ltd (CBO) | $321.75 Million | 5.76% | 1.17x | $650.87 Million |
| The Calmer Co International Ltd (CCO) | $1.38 Million | -272.44% | 1.13x | $2.07 Million |
| EVE Health Group Ltd (EVEDA) | $1.22 Million | -155.31% | 1.06x | $68.31 Million |
| Forbidden Foods Ltd (FFF) | $875.19K | -265.77% | 1.78x | $1.49 Million |
| Fonterra Shareholders Fund (FSF) | $388.00 Million | 0.00% | 0.00x | $26.81K |
| Health and Plant Protein Group Ltd (HPP) | $13.30 Million | 10.47% | 0.52x | $448.86K |